Invention Grant
- Patent Title: Composition for the treatment of cystic fibrosis
-
Application No.: US14978914Application Date: 2015-12-22
-
Publication No.: US10086001B2Publication Date: 2018-10-02
- Inventor: Michael Freissmuth , Xaver Koenig , Christina Just
- Applicant: SciPharm SàRL
- Applicant Address: LU Luxembourg
- Assignee: SciPharm SaRL
- Current Assignee: SciPharm SaRL
- Current Assignee Address: LU Luxembourg
- Agency: Loza & Loza, LLP
- Agent Michael Fedrick
- Priority: EP09167491 20090807
- Main IPC: A61K31/5575
- IPC: A61K31/5575 ; A61K9/00 ; A61K31/5578 ; A61K31/5585
Abstract:
The present invention provides compositions comprising a prostacyclin or prostacyclin analog, or a pharmaceutically acceptable salt thereof for use in preventing or treating cystic fibrosis. The invention also provides the use of a kit comprising a prostacyclin or prostacyclin analog for treating or preventing a condition associated with cystic fibrosis in a subject.
Public/Granted literature
- US20160175319A1 COMPOSITION FOR THE TREATMENT OF CYSTIC FIBROSIS Public/Granted day:2016-06-23
Information query
